Haemonetics
HAE
#3945
Rank
C$4.51 B
Marketcap
C$99.34
Share price
2.05%
Change (1 day)
2.98%
Change (1 year)

Haemonetics (HAE) - P/B ratio

P/B ratio as of June 2026 : 3.57

According to Haemonetics's latest financial reports the company has a price-to-book ratio of 2.46798.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Haemonetics - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-314.23-1.59%
2024-12-314.30-6.6%
2023-12-314.60-10.33%
2022-12-315.1338.29%
2021-12-313.71-55.76%
2020-12-318.38-16.79%
2019-12-3110.127.03%
2018-12-317.93112.77%
2017-12-313.7338.4%
2016-12-312.6918.35%
2015-12-312.28-1.49%
2014-12-312.31-12.78%
2013-12-312.65-2.13%
2012-12-312.7124.81%
2011-12-312.17-10.05%
2010-12-312.41-0.28%
2009-12-312.42-13.21%
2008-12-312.79-18.27%
2007-12-313.4129.93%
2006-12-312.62-15.43%
2005-12-313.1011.18%
2004-12-312.7923.95%
2003-12-312.25-4.25%
2002-12-312.35

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
6.91 93.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
2.14-40.01%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
3.30-7.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
1.64-53.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
1.66-53.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
5.25 46.96%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
1.80-49.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus Corporation
CERS
8.97 151.32%๐Ÿ‡บ๐Ÿ‡ธ USA